Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]BioXcel Therapeutics Inc"
Count: 18
Selected: 0
NCT IDTitle
NCT06041646Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
NCT05658510Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
NCT04251910Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
NCT04276883Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
NCT05276830An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
NCT05025605Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
NCT05665088Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
NCT05271552Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
NCT04268303Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
NCT03910660A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
NCT04010305Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
NCT05313386Study of BXCL501 In Agitation Associated With Delirium in ICU Patients
NCT04123574A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
NCT04470050Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
NCT04382170Dexmedetomidine Sublingual Film for the Management of Agitation in Delirium: Safety and Preliminary Efficacy
NCT05558982BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
NCT05712707Sublingual Dexmedetomidine for Treating Opioid Withdrawal
NCT04827056Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study